Presentation is loading. Please wait.

Presentation is loading. Please wait.

Women’s Health Center of Excellence Research at Ochsner

Published byByron Stevenson Modified over 6 years ago

Similar presentations

Presentation on theme: "Women’s Health Center of Excellence Research at Ochsner"— Presentation transcript:

1 Women’s Health Center of Excellence Research at Ochsner
June 2, 2017

2 CHAP Chronic Hypertension in Pregnancy
NIH funded study: 4700 women, 25 hospitals, 5 years Research question: To treat or not treat mild CHTN in pregnancy; conflicting evidence Subjects randomized (1:1) to: Treatment: maintain BP <140/90 using labetalol and/or nifedipine ER Standard: no treatment unless BP increases to ≥160/105 Pragmatic design- similar to routine care Followed through 6 weeks postpartum

3 Prevena-C Multicenter Trial Prophylactic Negative Pressure Wound Therapy in Obese Women at Cesarean: a Multicenter Randomized Trial Large NIH funded study- 4 sites, 2850 subjects total Objective: Assess effectiveness, safety, and cost-effectiveness of prophylactic negative pressure wound therapy in reducing rate of surgical site infections after cesareans in obese women Includes both planned and unplanned c/s Patients randomized 1:1 to either: Prevena wound vacuum device Standard bandage dressing

4 Maternal-Fetal Medicine Units (MFMU) Network
National Institute of Child Health and Human Development (NICHD) created Network in 1986 Current network comprised of 14 university based clinical centers and a data coordinating center Ochsner is sub-site to UAB Designed to conduct perinatal studies to improve maternal and fetal outcome with emphasis on randomized controlled trials Current/starting MFMU Network trials: ARRIVE Prospect

5 ARRIVE A Randomized Trial of Induction Versus Expectant Management
Research question: Does elective induction of labor in nulliparous women at 39 weeks improve perinatal outcome compared with expectant management? Design: randomized, controlled study 6000 women- 2 arms Elective induction 39w 0d to 39w 4d Expectant management until 40w 5d+ Followed through 6 weeks postpartum

6 PROSPECT A Randomized Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation with a Short Cervix Primary Hypothesis- In women with twin gestation with short cervical length, risk of preterm birth < 35 weeks is reduced with: Arabin cervical pessary Vaginal progesterone Design: 3 groups- pessary, progesterone, placebo drug Randomized after ultrasound shows short cervix Drug/device until 35 weeks Followed through outcome

7 Blood Draws Studies- Industry Sponsored
Sera Prognostics TREETOP study Validation of PreTRM test to predict preterm birth Development of new tests to predict preterm birth Population: Healthy pregnant women <22 weeks Chart review through delivery and postpartum Progenity, Inc. PRO-100 Evaluate screening method for characterizing chromosomal defects, deletions, aberrations in maternal blood Population: Pregnant women at risk for abnormality with CVS or amniocentesis scheduled

8 Women’s Health Biobank
Samples for both in-house and commercial Control patients- urine Pregnant patients- various time points in pregnancy and delivery Blood Amniotic fluid Cord amniotic fluid Placenta Urine Various treatments- frozen, formalin, RNAlater

9 Problem Pregnancy Exosomes
Enroll 50 pregnant women recently diagnosed GDM, preeclampsia, or FGR- 2nd or 3rd trimester 50 matched controls Collect 12ml blood sample (EDTA) & send to UQ for exosome analysis after consent upon admission for delivery morning after delivery Follow outcomes

10 EGGO Early Gestational Diabetes Screening in Gravid Obese Women
Obese pregnant women will be randomized to GDM screening Early weeks GA Routine weeks GA Outcomes will be ascertained Nothing done in L&D, but may see in clinic Data to be abstracted

11 PPROM A Randomized Double-Blind Trial Comparing the Impact of 1 vs 2 Courses of Anetnatal Steroids on Neonatal Outcome in Patients with Prelabor Premature Rupture of Membranes Compare 1 vs 2 doses of antenatal corticosteroids in women with expectantly managed PPROM <33weeks GA 2nd blinded course given 7+ days after 1st

12 AbbVie Elagolix Elagolix- novel, orally administered gonadotropin-releasing hormone antagonist (GnRH Antagonist) Alters level of pituitary GnRH suppression so, titrating circulating estrogen levels are achieved May provide relief from pain associated with endometriosis and uterine fibroids Studied in multiple clinical trials- 2 at Ochsner

13 Contact information- at Baptist Chris Servay- x73039 and Kate Garvey x-35967 Sherri Longo, MD- CHAP, ARRIVE, PROSPECT, Prevena-C, TREETOP, Progenity-100, exosomes, EGGO, PPROM studies Nicolle Crovetto- x Biobank Donnalee Trapani- x72864 Elagolix studies

Download ppt "Women’s Health Center of Excellence Research at Ochsner"

Similar presentations

 may be efective in preventing SGA birth in women at high risk of preeclampsia although the effect size is small. (c)

 may be efective in preventing SGA birth in women at high risk of preeclampsia although the effect size is small. (c)
Care of the pregnant woman Year 2 Lent term. The Case 38 year old booked at 12 weeks gestation in the antenatal clinic Expecting her third baby 1 st baby.

Care of the pregnant woman Year 2 Lent term. The Case 38 year old booked at 12 weeks gestation in the antenatal clinic Expecting her third baby 1 st baby.
Fetal Testing During Pregnancy

Fetal Testing During Pregnancy
Pretem Labor Ramzy Nakad, MD.

Pretem Labor Ramzy Nakad, MD.
UOG Journal Club: September 2012 Perinatal outcome in women treated with progesterone for the prevention of preterm birth: a meta-analysis Sotiriadis A,

UOG Journal Club: September 2012 Perinatal outcome in women treated with progesterone for the prevention of preterm birth: a meta-analysis Sotiriadis A,
Understanding the Etiology of Premature Rupture of Membranes Amy P. Murtha, MD Vice Chair for Research Obstetrics and Gynecology.

Understanding the Etiology of Premature Rupture of Membranes Amy P. Murtha, MD Vice Chair for Research Obstetrics and Gynecology.
Gestational diabetes mellitus (GDM), a common medical complication of pregnancy, is defined as “any degree of glucose intolerance with onset or first.

Gestational diabetes mellitus (GDM), a common medical complication of pregnancy, is defined as “any degree of glucose intolerance with onset or first.
Illustration of the evaluation of risk prediction models in randomized trials Examples from women’s health studies Parvin Tajik, MD PhD candidate Department.

Illustration of the evaluation of risk prediction models in randomized trials Examples from women’s health studies Parvin Tajik, MD PhD candidate Department.
Progesterone Therapy for Preterm Labor Perinatal Conference April 14, 2006.

Progesterone Therapy for Preterm Labor Perinatal Conference April 14, 2006.
Pregnancy Outcome Prediction Study University Department of Obstetrics and Gynaecology; PI – Professor Gordon CS Smith BACKGROUND The current pattern of.

Pregnancy Outcome Prediction Study University Department of Obstetrics and Gynaecology; PI – Professor Gordon CS Smith BACKGROUND The current pattern of.
Introduction  Preterm birth is the leading cause of perinatal death.  Handicap in children and the vast majority of mortality and morbidity relates.

Introduction  Preterm birth is the leading cause of perinatal death.  Handicap in children and the vast majority of mortality and morbidity relates.
Normal physiology of pregnancy First trimester-Increased insulin sensitivity. Late 2 nd and 3 rd trimester insulin resistance possible associated with.

Normal physiology of pregnancy First trimester-Increased insulin sensitivity. Late 2 nd and 3 rd trimester insulin resistance possible associated with.
William Goodnight, MD, MSCR Assistant Professor Division of Maternal Fetal Medicine UNC Chapel Hill School of Medicine.

William Goodnight, MD, MSCR Assistant Professor Division of Maternal Fetal Medicine UNC Chapel Hill School of Medicine.
The State of Ohio Universal Prenatal Booking David S. McKenna, MD, RDMS Maternal-Fetal Medicine Miami Valley Hospital, Dayton OH.

The State of Ohio Universal Prenatal Booking David S. McKenna, MD, RDMS Maternal-Fetal Medicine Miami Valley Hospital, Dayton OH.
Hypertension in Pregnancy

Hypertension in Pregnancy
Diseases and Conditions of Pregnancy pre-eclampsia once called toxemia –a pregnancy disease in which symptoms are –hypertension –protein in the urine –Swelling.

Diseases and Conditions of Pregnancy pre-eclampsia once called toxemia –a pregnancy disease in which symptoms are –hypertension –protein in the urine –Swelling.
NIH/NICHD ACTIVITIES RELATED TO PREVENTING PRETERM BIRTH Catherine Y. Spong, M.D. Deputy Director.

NIH/NICHD ACTIVITIES RELATED TO PREVENTING PRETERM BIRTH Catherine Y. Spong, M.D. Deputy Director.
TEMPLATE DESIGN © 2008 www.PosterPresentations.com Diet Plus Insulin Compared to Diet Alone In The Treatment of GDM Mothers in HUSM, Kelantan. Wan Faizah.

TEMPLATE DESIGN © Diet Plus Insulin Compared to Diet Alone In The Treatment of GDM Mothers in HUSM, Kelantan. Wan Faizah.
In the name of God.

In the name of God.
Premature Delivery Premature Rupture of Membrane Prolonged Pregnancy, Multiple Pregnancy Women Hospital, School of Medical, ZheJiang University Yang Xiao.

Premature Delivery Premature Rupture of Membrane Prolonged Pregnancy, Multiple Pregnancy Women Hospital, School of Medical, ZheJiang University Yang Xiao.

Similar presentations

Ads by Google